| Description | Gelucire 44/14 (Gelucire 14/44) acts as a nonionic surface-active excipient and improves fat absorption in rats with impaired lipolysis. |
| In vivo | Gelucire 44/14 能够用于制备针对实验感染大鼠 Hymenolepis nana 的纳米载体，提高体口服吡喹酮的生物利用度[1]。 |
| Synonyms | Gelucire 14/44 |
| molecular weight | N/A |
| CAS | 121548-04-7 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | Ethanol: 50 mg/mL, Sonication is recommended. |
| References | 1. Arafa WM,et al. Tunable Polymeric Mixed Micellar Nanoassemblies of Lutrol F127/Gelucire 44/14 for Oral Delivery of Praziquantel: A Promising Nanovector against Hymenolepis nana in Experimentally-Infected Rats. Pharmaceutics. 2022 Sep 23;14(10):2023. |